271 related articles for article (PubMed ID: 16859900)
21. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens.
Kaewsrichan J; Peeyananjarassri K; Kongprasertkit J
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):75-83. PubMed ID: 16965354
[TBL] [Abstract][Full Text] [Related]
22. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections.
Gupta K; Stapleton AE; Hooton TM; Roberts PL; Fennell CL; Stamm WE
J Infect Dis; 1998 Aug; 178(2):446-50. PubMed ID: 9697725
[TBL] [Abstract][Full Text] [Related]
23. Can vaginal lactobacillus suppositories help reduce urinary tract infections?
Shoureshi PS; Niino C; Eilber KS
Int Urogynecol J; 2023 Nov; 34(11):2713-2718. PubMed ID: 37392226
[TBL] [Abstract][Full Text] [Related]
24. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis.
Hemmerling A; Harrison W; Schroeder A; Park J; Korn A; Shiboski S; Foster-Rosales A; Cohen CR
Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497
[TBL] [Abstract][Full Text] [Related]
25. 14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
Cai T; Mazzoli S; Nesi G; Boddi V; Mondaini N; Bartoletti R
J Chemother; 2009 Nov; 21(5):535-41. PubMed ID: 19933045
[TBL] [Abstract][Full Text] [Related]
26. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor®) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study.
Donders GG; Van Bulck B; Van de Walle P; Kaiser RR; Pohlig G; Gonser S; Graf F
Gynecol Obstet Invest; 2010; 70(4):264-72. PubMed ID: 21051846
[TBL] [Abstract][Full Text] [Related]
27. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.
Stapleton AE; Au-Yeung M; Hooton TM; Fredricks DN; Roberts PL; Czaja CA; Yarova-Yarovaya Y; Fiedler T; Cox M; Stamm WE
Clin Infect Dis; 2011 May; 52(10):1212-7. PubMed ID: 21498386
[TBL] [Abstract][Full Text] [Related]
28. [Vaginal ecosystem].
Kovachev S
Akush Ginekol (Sofiia); 2011; 50(3):41-9. PubMed ID: 21916315
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus gasseri isolated from the vaginal tract of cattle.
Otero MC; Nader-Macías ME
Anim Reprod Sci; 2006 Nov; 96(1-2):35-46. PubMed ID: 16386389
[TBL] [Abstract][Full Text] [Related]
30. [Recurrent urinary tract infection in women].
Valdevenito S JP
Rev Chilena Infectol; 2008 Aug; 25(4):268-76. PubMed ID: 18769773
[TBL] [Abstract][Full Text] [Related]
31. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study.
Constantinides C; Manousakas T; Nikolopoulos P; Stanitsas A; Haritopoulos K; Giannopoulos A
BJU Int; 2004 Jun; 93(9):1262-6. PubMed ID: 15180619
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen peroxide producing lactobacilli in women with vaginal infections.
Mijac VD; Dukić SV; Opavski NZ; Dukić MK; Ranin LT
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):69-76. PubMed ID: 16814920
[TBL] [Abstract][Full Text] [Related]
33. Some probiotic properties of vaginal lactobacilli isolated from healthy women.
Aslim B; Kilic E
Jpn J Infect Dis; 2006 Aug; 59(4):249-53. PubMed ID: 16936344
[TBL] [Abstract][Full Text] [Related]
34. [Study of vaginal and intestinal microflora of women in the prenatal period and its correction in dysbacteriosis].
Podgorskiĭ VS; Liaskovskiĭ TM; Kovalenko NK; Oleshchenko LT
Mikrobiol Z; 2006; 68(2):92-104. PubMed ID: 16786633
[TBL] [Abstract][Full Text] [Related]
35. Bacterial interference--is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?
Sundén F; Håkansson L; Ljunggren E; Wullt B
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S26-9. PubMed ID: 16843646
[TBL] [Abstract][Full Text] [Related]
36. Reduced quantity and hydrogen-peroxide production of vaginal lactobacilli in HIV positive women.
Knezević A; Stepanović S; Cupić M; Jevtović D; Ranin J; Jovanović T
Biomed Pharmacother; 2005 Oct; 59(9):521-3. PubMed ID: 16271844
[TBL] [Abstract][Full Text] [Related]
37. Vaginal Lactobacillus isolates inhibit uropathogenic Escherichia coli.
Atassi F; Brassart D; Grob P; Graf F; Servin AL
FEMS Microbiol Lett; 2006 Apr; 257(1):132-8. PubMed ID: 16553843
[TBL] [Abstract][Full Text] [Related]
38. [Non-antibiotic prophylaxis for recurrent urinary-tract infections].
Beerepoot MA; ter Riet G; Verbon A; Nys S; de Reijke TM; Geerlings SE
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):541-4. PubMed ID: 16566416
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells.
Osset J; Bartolomé RM; García E; Andreu A
J Infect Dis; 2001 Feb; 183(3):485-91. PubMed ID: 11133381
[TBL] [Abstract][Full Text] [Related]
40. Lactobacilli for prevention of urogenital infections: a review.
Marelli G; Papaleo E; Ferrari A
Eur Rev Med Pharmacol Sci; 2004; 8(2):87-95. PubMed ID: 15267122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
